Your case report title should clearly indicate the main focus of your case. Include key terms, keep it concise, and avoid jargon. Remember, characters in your title are included in the size limit.

Author information does not count towards the character limit.

The Submitting Author must meet the eligibility requirements above and is automatically listed as first and presenting author. You may change this after adding additional authors. It is the submitting author’s responsibility to notify all named authors that they will be listed as co-authors on the abstract.

The Presenting Author must meet the eligibility requirements above and will be the only one to receive the acceptance or rejection notification on 13 December. It is their responsibility to inform all co-authors of the submission’s outcome. If the abstract is accepted, a presentation invitation will be sent to the Presenting Author on 3 January, 2025. They will have until 31 January to confirm or withdraw the presentation, or to change the presenting author to another co-author listed on the abstract. The Presenting Author must register for and attend the Annual Meeting in person.

Co-Authors included should be those who contribute significantly to the intellectual content of the abstract (maximum 50 authors). When adding authors, include the Full Name, Degree, Affiliation, and Email Address of each author. You can use the ISHLT database search tool on the submission site to find and add your authors. Authors will be listed in the author block in the order they are added but can be rearranged after adding.

Your case report can be submitted only once. Submitting the same case report to different categories or splitting one case into multiple case reports is not allowed. If the case reports are too similar to be considered separate studies or if the same case report is submitted to multiple categories, all versions may be rejected.

Case Report Categories are separated into four core therapies:

• HEART (Advanced Heart Failure & Transplantation)
• LUNG (Advanced Lung Failure & Transplantation)
• MCS (Mechanical Circulatory Support)
• PVD (Pulmonary Vascular Disease (PAH & CTEPH)

You will select only one of the following categories:

HEART

• HEART-CASE-Donor Related/Early Complications Post-Transplant
• HEART-CASE-Heart Failure
• HEART-CASE-Infectious Diseases
• HEART-CASE-Long Term Follow-up Post Transplant
• HEART-CASE-Multidisciplinary Clinical Conundrums
• HEART-CASE-Nursing/Allied Health/Other
• HEART-CASE-Pediatrics
• HEART-CASE-Rejection
• HEART-CASE-Surgical

LUNG

• LUNG-CASE-Donor/Surgical/Anesthesia Considerations
• LUNG-CASE-Drug Induced Complications
• LUNG-CASE-Immunology/Rejection
• LUNG-CASE-Infectious Disease
• LUNG-CASE-Nursing/Allied Health/Other
• LUNG-CASE-Post-Transplant Complications (Other, Non-Infectious Non-Immune)

MCS

• MCS-CASE-Cardiogenic Shock
• MCS-CASE-Durable Circulatory Support
• MCS-CASE-Infectious Complications
• MCS-CASE-Myocardial Recovery/Hemodynamics
• MCS-CASE-Nursing/Allied Health/Other
• MCS-CASE-Pediatrics/Congenital Heart Disease
• MCS-CASE-Surgical Approaches/Peri-operative Management
• MCS-CASE-Temporary Circulatory Support

PVD

• PVD-CASE-Nursing/Allied Health/Other
• PVD-CASE-Right Heart Failure
• PVD-CASE-Surgical/Interventional/Anesthesia Considerations
• PVD-CASE-WHO Group I Pulmonary Arterial Hypertension
• PVD-CASE-WHO Group II/III
• PVD-CASE-WHO Group IV CTED/CTEPH

You will be asked to select the Primary Practice Area most relevant to your research abstract (which might not be your primary practice area), the Secondary Practice Area, and any additional practice areas applicable from the following list:

• Anesthesiology and Critical Care
• Cardiology
• Cardiothoracic Surgery
• Infectious Diseases
• Nursing and Allied Health
• Pathology
• Pediatrics
• Pharmacy
• Pulmonology
• Research and Immunology

Each year, the ISHLT conducts an award session entitled, Early Career and Trainees Clinical Case Dilemmas: The Best of the Best. The top four case reports (one from each core therapy) will be selected for oral presentation in this session. You will answer a question on the submission site to confirm the Presenting Author’s eigibility for this award. If your case report is accepted but isn’t one of the top four, it will be selected for poster presentation. For more information on this and other awards, visit Scientific Abstract Awards.

Several questions will be asked regarding funding:

• Is the presenting author an employee or owner of a company whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients? (Yes/No). If yes, identify the healthcare company.
• Is this abstract being funded (in part or in whole) by a healthcare company? (Yes/No). If yes, identify the healthcare company.

In this step, the body of the case report (Introduction, Case Report, and Summary) and any tables or images are entered. Follow the links on the site to enter each element. Remember, a table or image removes 320 characters from the limit.

• Introduction: Briefly explains the context and relevance of the case.
• Case Report: Outlines the patient's clinical information, including history, physical examination findings, diagnostic tests, and treatment provided.
• Summary: Summarizes the main takeaway or clinical significance of the case.

A $25 (USD) processing fee must accompany each abstract. ISHLT accepts payment only in the form of MasterCard, Visa and American Express. Purchase orders, checks, and electronic bank transfers will not be accepted. This fee is non-refundable and used to cover the cost of submission and processing.

Use this opportunity to proofread your submission carefully. You can make corrections to any portion, including authors, up until the deadline. Edits to a submission are not permitted after the deadline.

If all submission steps are completed, the page will indicate the submission is COMPLETE and no further action is required. If one or more submission steps are not completed, the page will indicate the submission is INCOMPLETE and ask you to complete the required steps before the submission can be marked COMPLETE.